Clinical Trial Update: Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating paclitaxel with hyperthermic perfusion for patients with unresectable lung cancer or lung metastases; the study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Lung Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Cancer, Metastatic Cancer | Phase 1 | Status: COMPLETED